141 related articles for article (PubMed ID: 12716813)
1. Evaluation of urinary 8-hydroxydeoxy-guanosine as a novel biomarker of macrovascular complications in type 2 diabetes.
Nishikawa T; Sasahara T; Kiritoshi S; Sonoda K; Senokuchi T; Matsuo T; Kukidome D; Wake N; Matsumura T; Miyamura N; Sakakida M; Kishikawa H; Araki E
Diabetes Care; 2003 May; 26(5):1507-12. PubMed ID: 12716813
[TBL] [Abstract][Full Text] [Related]
2. Urinary 8-hydroxydeoxyguanosine levels in diabetic retinopathy patients.
Dong QY; Cui Y; Chen L; Song J; Sun L
Eur J Ophthalmol; 2008; 18(1):94-8. PubMed ID: 18203092
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 8-hydroxy-2'-deoxyguanosine (8-OHdG) levels using mass spectrometer and urine albumin creatinine ratio as a predictor of development of diabetic nephropathy.
Serdar M; Sertoglu E; Uyanik M; Tapan S; Akin K; Bilgi C; Kurt I
Free Radic Res; 2012 Oct; 46(10):1291-5. PubMed ID: 22789030
[TBL] [Abstract][Full Text] [Related]
4. Urinary 8-hydroxy-2'-deoxyguanosine as a novel biomarker for predicting cardiac events and evaluating the effectiveness of carvedilol treatment in patients with chronic systolic heart failure.
Susa T; Kobayashi S; Tanaka T; Murakami W; Akashi S; Kunitsugu I; Okuda S; Doi M; Wada Y; Nao T; Yamada J; Ueyama T; Okamura T; Yano M; Matsuzaki M
Circ J; 2012; 76(1):117-26. PubMed ID: 22008315
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary albumin excretion is a marker of risk for retinopathy and coronary heart disease in patients with type 2 diabetes mellitus.
Lunetta M; Infantone L; Calogero AE; Infantone E
Diabetes Res Clin Pract; 1998 Apr; 40(1):45-51. PubMed ID: 9699090
[TBL] [Abstract][Full Text] [Related]
6. Oxidative DNA damage is associated with inflammatory response, insulin resistance and microvascular complications in type 2 diabetes.
Tatsch E; De Carvalho JA; Hausen BS; Bollick YS; Torbitz VD; Duarte T; Scolari R; Duarte MM; Londero SW; Vaucher RA; Premaor MO; Comim FV; Moresco RN
Mutat Res; 2015 Dec; 782():17-22. PubMed ID: 26520687
[TBL] [Abstract][Full Text] [Related]
7. Family histories of Type II diabetes and hypertension predict intima-media thickness in patients with Type I diabetes.
Mäkimattila S; Ylitalo K; Schlenzka A; Taskinen MR; Summanen P; Syvänne M; Yki-Järvinen H
Diabetologia; 2002 May; 45(5):711-8. PubMed ID: 12107752
[TBL] [Abstract][Full Text] [Related]
8. Increased intimal-medial thickness in newly detected type 2 diabetes: risk factors.
Temelkova-Kurktschiev TS; Koehler C; Leonhardt W; Schaper F; Henkel E; Siegert G; Hanefeld M
Diabetes Care; 1999 Feb; 22(2):333-8. PubMed ID: 10333954
[TBL] [Abstract][Full Text] [Related]
9. Decrease in carotid intima media thickness after 1 year of cilostazol treatment in patients with type 2 diabetes mellitus.
Ahn CW; Lee HC; Park SW; Song YD; Huh KB; Oh SJ; Kim YS; Choi YK; Kim JM; Lee TH
Diabetes Res Clin Pract; 2001 Apr; 52(1):45-53. PubMed ID: 11182215
[TBL] [Abstract][Full Text] [Related]
10. Carotid intima-media thickness in relation to macrovascular disease in patients with type 2 diabetes mellitus.
Mudríková T; Szabová E; Tkác I
Wien Klin Wochenschr; 2000 Oct; 112(20):887-91. PubMed ID: 11244615
[TBL] [Abstract][Full Text] [Related]
11. Urinary albumin levels in the normal range determine arterial wall thickness in adults with Type 2 diabetes: a FIELD substudy.
Keech AC; Grieve SM; Patel A; Griffiths K; Skilton M; Watts GF; Marwick TH; Groshens M; Celermajer DS
Diabet Med; 2005 Nov; 22(11):1558-65. PubMed ID: 16241922
[TBL] [Abstract][Full Text] [Related]
12. [Correlation analysis between diabetic retinopathy and early atherosclerotic changes in adolescents with type 1 diabetes -- preliminary report].
Głowińska-Olszewska B; Urban M; Urban B; Tołwińska J
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):96-102. PubMed ID: 16813713
[TBL] [Abstract][Full Text] [Related]
13. The urinary concentration of sialic acid is increased in non-insulin-dependent diabetic patients with microangiopathy: a possible useful marker for diabetic microangiopathy.
Suzuki K; Ishida H; Sugimoto C; Taguchi Y; Matsuda H; Nosaka K; Someya Y; Kadowaki S; Seino Y
Diabet Med; 1995 Dec; 12(12):1092-6. PubMed ID: 8750219
[TBL] [Abstract][Full Text] [Related]
14. Study of urinary 8-hydroxydeoxyguanosine as a biomarker of oxidative DNA damage in diabetic nephropathy patients.
Xu GW; Yao QH; Weng QF; Su BL; Zhang X; Xiong JH
J Pharm Biomed Anal; 2004 Sep; 36(1):101-4. PubMed ID: 15351053
[TBL] [Abstract][Full Text] [Related]
15. Urinary adiponectin excretion: a novel marker for vascular damage in type 2 diabetes.
von Eynatten M; Liu D; Hock C; Oikonomou D; Baumann M; Allolio B; Korosoglou G; Morcos M; Campean V; Amann K; Lutz J; Heemann U; Nawroth PP; Bierhaus A; Humpert PM
Diabetes; 2009 Sep; 58(9):2093-9. PubMed ID: 19509019
[TBL] [Abstract][Full Text] [Related]
16. Postprandial hypertriglyceridemia and carotid intima-media thickness in north Indian type 2 diabetic subjects.
Ahmad J; Hameed B; Das G; Siddiqui MA; Ahmad I
Diabetes Res Clin Pract; 2005 Aug; 69(2):142-50. PubMed ID: 15955588
[TBL] [Abstract][Full Text] [Related]
17. [Subclinical arteriosclerosis in patients with newly diagnosed type 2 diabetes mellitus. Demonstration by high-resolution ultrasound measurements of intima-media thickness of the common carotid and femoral arteries].
Frost D; Fröhlich B; Beischer W
Dtsch Med Wochenschr; 2000 May; 125(21):648-54. PubMed ID: 10874902
[TBL] [Abstract][Full Text] [Related]
18. Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.
de Vries R; Dallinga-Thie GM; Smit AJ; Wolffenbuttel BH; van Tol A; Dullaart RP
Diabetologia; 2006 Feb; 49(2):398-404. PubMed ID: 16374627
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.
Shichiri M; Kishikawa H; Ohkubo Y; Wake N
Diabetes Care; 2000 Apr; 23 Suppl 2():B21-9. PubMed ID: 10860187
[TBL] [Abstract][Full Text] [Related]
20. Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM.
Savage S; Estacio RO; Jeffers B; Schrier RW
Diabetes Care; 1996 Nov; 19(11):1243-8. PubMed ID: 8908388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
